EQL Pharma Investor Relations

Axel Schörling

President and CEO

Education

MSc Engineering Physics, Chalmers and MSc Financial Economics, School of Business in Gothenburg.

Born

1986

Shareholding

257,113 shares and 400,000 call options

Professional experience

Axel Schörling has a background as a management consultant at BearingPoint and most recently came from a role as Director of Perstorp’s Business Controlling team. Overall, he has extensive experience from a number of industries and assignments in logistics and supply chain from an operational / financial perspective.